Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

EDA Spotlight on Executive-in-Residence: Sam Kongsamut

2/26/2016

1 Comment

 
​Trenton, NJ ― The New Jersey Economic Development Authority (EDA) recently unveiled its second group of Executive-in-Residence (EIR) appointees.  These highly-skilled life sciences professionals will mentor and advise emerging companies at EDA’s Commercialization Center for Innovative Technologies (CCIT) in North Brunswick.  The EIR program was created in collaboration with BioNJ. 
 
Over the past few weeks, @NJEDATech has delved into the back-stories of these EIRs.
 
Today we highlight our fifth EIR, Sam Kongsamut, PhD, of Madison.
 
Sam Kongsamut, PhD, of Madison (EIR –Investment and Partnering Strategies) is an entrepreneurial neuroscientist with vast pharmaceutical research and development (R&D) experience, as well as business development experience. 
​Kongsamut has spent his career involved with large and small companies, including Sanofi, where he was the Director of External Innovation, Aging Therapeutic Strategy Unit.
 
He led a variety of multi-disciplinary drug discovery and development projects in neuroscience and aging (including schizophrenia, Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis). Kongsamut helped to lead these therapies through preclinical development and into clinical trials.
 
Kongsamut spends his time at CCIT providing guidance to tenant companies on the best ways to pitch investors and create partnerships within the industry.  On Wednesday, February 24, Kongsamut will deliver a presentation at CCIT entitled The Importance of the Story in Team Building and Fundraising. The program is open to the technology community at large.
 
As a co-organizer of Launch NJ Life Sciences Hub, a Meetup group for entrepreneurs, Kongsamut keeps a finger on the pulse on what’s happening in New Jersey’s technology scene. He is also an adjunct professor at Rutgers University.
 
Kongsamut earned a Master of Science degree from the University of Illinois at Chicago, and a PhD in Neuropharmacology from the University of Chicago.  He subsequently became a Post-doctoral fellow at the Cornell University Medical College and then a Post-doctoral associate at the Yale University School of Medicine.
 
@NJEDATech asked Kongsamut about his experience with the EIR program and his plans for the future:
 
Why did you choose to apply to the Executive-in-Residence program?
 
I have known about the EIR Program since its beginning, and had recommended some former colleagues to apply.  In June 2015, I had just left a small biotechnology company, attended the BIO International Convention in Philadelphia, and met up with BioNJ Vice President of Talent Services Vicki Gaddy and then-CCIT Program Manager Anne-Marie Maman at the New Jersey Pavilion.  Both of them urged me to consider serving as an EIR at CCIT. I applied shortly thereafter, was interviewed in November, and the rest, as they say, is history.
 
The pharmaceutical industry is undergoing a major structural change from R&D performed in large corporate labs to R&D sourced externally.  The term used for this is “external” or “open” innovation.  
 
I worked at Sanofi on external innovation until 2012 when the R&D site in Bridgewater closed. I have since been working with entrepreneurs and small companies, through mentorship and consulting; I have started a company myself, and worked for a small, virtual biotechnology company of seven people.
 
I have also been working to try to convert big company scientists into entrepreneurs. Given my extensive background, I believe mentoring at CCIT will give me the opportunity to help smaller biotechnology companies grow and succeed.   
 
I’ve already had discussions with a few CCIT companies, including Grace Therapeutics, Hudson BioPharma, and Urigen, and hope to be helpful to them and others.
 
What do you hope to get out of this Executive-in-Residence program?
 
I hope to make more connections with entrepreneurial life science companies to both learn more about the challenges of entrepreneurship, and to help the companies make connections to further their development.  
 
The biopharmaceutical industry is an inherently multidisciplinary effort; with entrepreneurs, the multiple disciplines are typically outside the company. Hence, connections are critical.
 
What’s the best piece of advice you’ve heard over the years that you hope to impart on these emerging life sciences companies?
 
Entrepreneurship is hard. Pharmaceutical R&D is hard. You should be congratulated on having the passion and energy to combine two really difficult things. Now get to work building your company and connecting with all the people you need to make it happen.

What is the next challenge you want to undertake in your career?
 
If I return to a pharmaceutical company, I would like it to be in an external innovation role.  More likely, I will continue to work to develop the entrepreneurial ecosystem through consulting, advising and educating (through groups like Launch NJ Life Sciences Hub) to help life scientists remain in New Jersey, and continue to develop innovative medicines here.
 
And if I find a technology or project that is particularly interesting, I may join or start a biotechnology company.
 
More information about EIR program, including eligibility, can be found at www.njeda.com/EIR.
 
 
1 Comment
Joanne Gere link
3/1/2016 12:43:05 pm

We're very lucky and proud to have Sam on our Scientific Advisory Board! He's been a champion for the life science ecosystem for many years, and brings both expertise and creativity to our work! www.biopharmaresearchcouncil.org

Reply



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619